Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cognition-enhancing activity of novel inverse agonist of GABA-A alpha 5 subunit receptors

Jan. 3, 2008

Studies support serotonin inverse agonist combination therapy for schizophrenia

Jan. 3, 2008

Wide therapeutic potential seen for sanofi-aventis' GlyT-1 inhibitor SSR-103800

Jan. 2, 2008

Pramipexole shows potential in treatment-resistant depression

Dec. 31, 2007

Bupropion ameliorates methamphetamine dependence in some patients

Dec. 28, 2007

Preliminary phase I results with AT-9283 in hematological malignancies encouraging

Dec. 28, 2007

Activity seen with SNS-595 in acute leukemia patients

Dec. 28, 2007

Phase I/II study of Oncohist in leukemia progresses

Dec. 28, 2007

Adjunctive N-acetyl cysteine beneficial in schizophrenia patients

Dec. 27, 2007

Btk inhibition with PCI-32765 evaluated in mouse lymphoma models

Dec. 27, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...